MTOR and Alzheimer disease: It has been shown that PKCγ is upstream of several signaling pathways, including ERK and the mammalian target of rapamycin (mTOR) (Menard and Quirion, 2012), which are involved in several neurological disorders, including AD (Klafki et al., 2009; Ma et al., 2010).